Skip to content
Open access

Whole-body MRI with DWIBS and choline PET/CT for detecting oligoprogressive castration-resistant prostate cancer recurrence.

Oct 2026 · Fukushima Journal of Medical Science · 0 citations
Medicine

Abstract

The diagnostic options for patients with advanced prostate cancer have expanded with the development of next-generation imaging modalities. These include whole-body magnetic resonance imaging (WB-MRI) with diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) and molecular positron emission tomography/computed tomography (PET/CT) using choline or prostate-specific membrane antigen radiotracers. Such modalities improve the detection of whole-body nodal and bony metastases in patients with advanced prostate cancer. A 63-year-old man with castration-resistant prostate cancer (CRPC) underwent stereotactic body radiotherapy (SBRT) targeting two pelvic nodal metastases identified by WB-MRI with DWIBS and subsequently confirmed by 11C-choline PET/CT. This case highlights the potential role of 11C-choline PET/CT and corresponding local treatment in the management of oligoprogressive CRPC.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.